MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-DL-04-0002125
Recombigen Laboratories Private Limited - healthcare in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹17.85 Cr
▼ 41% YoY
Net profit · FY 2025
₹26.01 Lakh
Net margin 1.5%
EBITDA · FY 2025
₹1.39 Cr
EBITDA margin 7.8%
Authorised capital
₹1.25 Cr
Registered with MCA
Paid-up capital
₹51.1 Lakh
Issued & subscribed
Open charges
₹10.35 Cr
Satisfied ₹1.1 Cr
Company age
27 yrs
Est. 1999
Employees · EPFO
7
Provident fund records
About Recombigen Laboratories Private Limited
Data last updated:
Recombigen Laboratories Private Limited is a private limited company based in Delhi, India. It operates in the medical consumables and supplies segment of the healthcare sector. It was incorporated on 07 January 1999 and has been in existence for over 27 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24231DL1999PTC097838. Its GSTIN is 07AABCR5249N1ZY (Delhi). The company holds 6 GST registrations, of which 5 are active.
The company has an authorised share capital of ₹1.25 Cr and a paid-up capital of ₹51.1 Lakh. It is led by directors Radhika Beri and Rajesh Beri.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Prop. No. 98 Phase – II Badli Industrial Estate, Delhi, India – 110042.
As per the financials filed for FY 2025, the company reported a revenue of ₹17.85 Cr, a decline of 41% compared to the previous year. For the same year it recorded a net profit of ₹26.01 Lakh (net margin 1.5%) and EBITDA of ₹1.39 Cr (EBITDA margin 7.8%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 11% over five years.
The company has about 7 employees on its provident fund (EPFO) records.
The company is associated with 2 brands: Recombigen Laboratories and Recombigen. As per MCA filings, the company has open charges of ₹10.35 Cr and satisfied charges of ₹1.1 Cr on record. Court records list 9 cases involving the company, including 5 filed by the company and 4 filed against it; 4 cases are pending.
Recombigen Laboratories Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-04-0002125). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website recombigen.com.
Company details
CIN U24231DL1999PTC097838
Registration Number 097838
Incorporation Date 07 January 1999
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-DL-04-0002125
Key People
Radhika Beri Director Rajesh Beri Director Recognitions & Rankings of Recombigen Laboratories
Contact details
Recombigen Laboratories Private Limited's registered office is in Delhi, Delhi. Its website is recombigen.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressProp. No. 98 Phase – II Badli Industrial Estate, Delhi, India – 110042
- IndustryHealthcare, Medical Consumables & Supplies
To see the full contact details of Recombigen Laboratories Private Limited, buy the company report.
Comprehensive company report
Recombigen Laboratories Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Recombigen Laboratories operates two associated brands: Recombigen Laboratories and Recombigen. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures and supplies laboratory reagents, diagnostic kits, and accessories. | recombigen.in | |
| Manufactures diagnostic kits and laboratory accessories for medical use. | recombigen.com |
Business activity
The main business activity of Recombigen Laboratories is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Recombigen Laboratories Private Limited, buy the company report.
Financials of Recombigen Laboratories Private Limited
FY 2025 filings availableRecombigen Laboratories Private Limited reported revenue of ₹17.85 Cr (down 41% YoY) for FY 2025.
Revenue · FY 2025
₹17.85 Cr ▼ 41%
Net profit · FY 2025
₹26.01 Lakh margin 1.5%
EBITDA · FY 2025
₹1.39 Cr margin 7.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 41%
3 years · compounded
▼ 10%
5 years · compounded
▲ 11%
EBITDA CAGR growth
1 year
▼ 8%
3 years · compounded
▲ 8%
5 years · compounded
▲ 22%
Revenue fell 41% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 11%. EBITDA fell 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.39 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹26.01 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.8% | ||||
| Net Profit Margin | 1.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Recombigen Laboratories Private Limited, buy the company report.
Board of directors of Recombigen Laboratories Private Limited
Recombigen Laboratories has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Radhika Beri | Director | 20 Apr 2022 | 4 Years 6 Months | Current |
| Rajesh Beri | Director | 07 Jan 1999 | 27 Years 9 Months | Current |
Peer comparison
Recombigen Laboratories Private Limited is compared with the 4 companies closest to it by revenue in the Healthcare industry (Medical Consumables), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sevana Medineeds Private Limited | ₹18.01 Cr (FY 2025) | 9.0% | Kochi, Kerala, India | |||
| One Touch Medical Products Private Limited | ₹17.86 Cr (FY 2024) | 3.0% | Patna, Bihar, India | |||
| Recombigen Laboratories Private Limitedthis company | ₹17.85 Cr (FY 2025) | ₹26.01 Lakh | 1.5% | -41.0% | 7 | Delhi, India |
| Mediblue Healthcare Private Limited | ₹17.72 Cr (FY 2023) | -15.0% | Hyderabad, Telangana, India | |||
| S M S Scientific Products Pvt Ltd | ₹17.62 Cr (FY 2024) | -3.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Recombigen Laboratories Private Limited, buy the company report.
Auditor
Recombigen Laboratories Private Limited is audited by SURINDER VERMA ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SURINDER VERMA ASSOCIATES | FY 2023 | 006610N |
Shareholding
The shareholding of Recombigen Laboratories Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Recombigen Laboratories Private Limited, buy the company report.
Charges & borrowings
Open charges
₹10.35 Cr
Satisfied charges
₹1.1 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 08 Aug 2022 | 100633406 | Sidbi | ₹81 Lakh | Open | |
| 30 Jan 2021 | 100447845 | Others | ₹17.53 Lakh | Open | |
| 21 Jun 2019 | 100283959 | Axis Bank Limited | ₹19.16 Lakh | Open | |
| 21 Jun 2019 | 100283964 | Axis Bank Limited | ₹6.66 Lakh | Open | |
| 25 Oct 2017 | 100161772 | Yes Bank Limited | ₹9.11 Cr | Open |
To see the full charge records of Recombigen Laboratories Private Limited, buy the company report.
Total charge records: 7 View all charges
Legal cases
Recombigen Laboratories Private Limited has 9 court cases on record: 5 filed by Recombigen Laboratories, 4 filed against it. 4 cases are pending and 5 are disposed.
Total cases
9
Filed by the company
5
Filed against the company
4
Pending
4
Disposed
5
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 9 | 4 | 4 |
Cases on record (5 of 9)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, North West, Delhi | Court case (CS (COMM.)) | Filed by the company against Amazing Research Laboratories Ltd | Disposed |
| District court, North West, Delhi | Court case (CS (COMM.)) | Filed against the company by Amazing Research Laboratories Ltd | Disposed |
| District court, North, Delhi | Civil suit | Filed against the company by an individual | Pending |
| District court, West, Delhi | Cheque dishonour complaint | Filed against the company by an individual | Pending |
| District court, Akola, Maharashtra | Civil suit | Filed against the company by an individual | Pending |
To see the full case history of Recombigen Laboratories Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Recombigen Laboratories Private Limited has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 22 overdue payments to 4 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (4 of 4)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Kee Diagnostics Private Limited | |||
| an individual supplier | |||
| an individual supplier | |||
| an individual supplier |
To see the full MSME payment records of Recombigen Laboratories Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Recombigen Laboratories Private Limited has a workforce of 7 employees on its EPFO records as of Apr 08, 2024, across 1 active EPFO establishment.
Employee count
7
Active EPFO establishments
1
Employee growth
-12.5%
GST
Recombigen Laboratories has 6 GST registrations: 5 active and 1 cancelled or inactive. The first 4 active GSTINs are listed below.
Total GSTINs
6
Active
5
Cancelled / inactive
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AABCR5249N1ZY | Delhi | Active | 01 Jul 2017 |
| 29AABCR5249N1ZS | Karnataka | Active | 16 Mar 2023 |
| 36AABCR5249N1ZX | Telangana | Active | 12 Sep 2023 |
| 27AABCR5249N1ZW | Maharashtra | Active | 19 Oct 2023 |
To see the full GST registrations and return filing status of Recombigen Laboratories Private Limited, buy the company report.
Recent activity
Recombigen Laboratories Private Limited has 6 board changes on record since 1999: 3 appointments and 3 cessations. The latest: Rishu Beri ceased to be Director on 04 Jun 2025.
Charges
A charge with Yes Bank Limited of Rs. 9.11 Cr registered on 25 Oct 2017 with Charge ID 100161772 was modified on 22 Jan 2026.
AGM
Recombigen Laboratories Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Ceased
Rishu Beri ceased to be Director.
Filing
Recombigen Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi I.
Charges
A charge with Sidbi amounted to Rs. 0.81 Cr with Charge ID 100633406 was registered on 08 Aug 2022.
Appointed
Radhika Beri was appointed as Director.
Charges
A charge with Others amounted to Rs. 0.18 Cr with Charge ID 100447845 was registered on 30 Jan 2021.
Charges
A charge with Axis Bank Limited amounted to Rs. 0.19 Cr with Charge ID 100283959 was registered on 21 Jun 2019.
Charges
A charge with Axis Bank Limited amounted to Rs. 0.07 Cr with Charge ID 100283964 was registered on 21 Jun 2019.
Ceased
Radhika Beri ceased to be Director.
Appointed
Rishu Beri was appointed as Director.
Charges
A charge registered on 22 Jun 2013 via Charge ID 10519464 with Central Bank Of India was fully satisfied on 22 Jan 2018.
9 earlier events are in the company report.
Frequently asked questions
Recombigen Laboratories is an active private limited company based in Delhi, India. The company works in medical consumables and supplies, within the healthcare industry. It was incorporated on 07 January 1999 (27+ years old) and is registered under CIN U24231DL1999PTC097838.
Recombigen Laboratories has 2 current directors:
- Radhika Beri - Director
- Rajesh Beri - Director
The latest financial statements of Recombigen Laboratories on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Recombigen Laboratories is 07AABCR5249N1ZY, registered in Delhi. The company has 6 GST registrations in all, of which 5 are active and 1 is cancelled or inactive. Other active GSTINs include 29AABCR5249N1ZS (Karnataka), 36AABCR5249N1ZX (Telangana), 27AABCR5249N1ZW (Maharashtra).
The CIN (Corporate Identification Number) of Recombigen Laboratories is U24231DL1999PTC097838. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Recombigen Laboratories has 9 court cases on record: 5 filed by the company and 4 filed against it. 4 are pending.
Recombigen Laboratories was incorporated on 07 January 1999, making it 27+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Recombigen Laboratories by revenue are Sevana Medineeds Private Limited, One Touch Medical Products Private Limited, Mediblue Healthcare Private Limited, S M S Scientific Products Pvt Ltd, all in the Healthcare industry (Medical Consumables), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Rishu Beri ceased to be Director on 04 Jun 2025. Radhika Beri was appointed as Director on 20 Apr 2022. Radhika Beri ceased to be Director on 05 Apr 2019. Recombigen Laboratories has 6 board changes on record in total.
Yes, Recombigen Laboratories is registered as a small enterprise under Udyam registration (number: UDYAM-DL-04-0002125).
Recombigen Laboratories has 2 MSME Form 1 returns on record for the period ending Mar 2019, listing 22 overdue payments to 4 micro and small suppliers. The latest return was filed on 08 Jun 2019.
Recombigen Laboratories can be reached through the website recombigen.com. Its registered office is in Delhi, India.